Group 1: Financial Performance - The company recorded a provision for impairment of over 50 million in 2024, with nearly 30 million in Q1 2025, primarily due to inventory write-downs of pea starch influenced by market conditions [2][3] - The significant drop in profit in Q1 2025 was mainly due to changes in revenue structure and the market conditions of pea starch [3][5] - The company plans to implement a share buyback, but the loan funds for this purpose have not yet been received [2][5] Group 2: Business Strategy and Development - The company aims to become a leader in the pea industry chain, focusing on products like pea protein, noodles, and dietary fiber, while continuously extending its product line [3][4] - The company is actively expanding its raw material procurement channels to mitigate procurement risks [2][3] - New subsidiaries have been established to optimize management structure and resource allocation, enhancing operational efficiency [4][5] Group 3: Market and Product Insights - Pea protein and oligosaccharides are currently in the market development stage, with profitability yet to be established [4][5] - The Thai factory is expected to be completed in the second half of the year, with an additional production capacity of approximately 10,000 tons of protein [5][6] - The company is exploring various avenues for product development and market expansion, including potential AI and technology initiatives [5][6] Group 4: Shareholder Engagement and Value Creation - The company emphasizes maintaining good communication with investors and aims to create stable profits and implement a consistent cash dividend policy [5][6] - Concerns were raised about the impact of share buybacks on stock prices, with the company stating that stock price fluctuations are primarily due to market conditions [3][5] - The company has not identified any undisclosed significant information related to its operations [5][6]